DONALD GRIFFITH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sonnet BioTherapeutics Holdings, Inc.

Filing Date Source Excerpt
2022-08-25 Donald Griffith 91,186 shares (4) **

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22